161 related articles for article (PubMed ID: 2583457)
1. [Comparative evaluation of blast cell proliferation and effectiveness of combined chemotherapy in children with different immunocytological subvariants of acute lymphoblastic and nonlymphoblastic leukemia].
Golenko OD; Tupitsyn NN; Protasova AK; Balakirev SA; Kochetkova OD
Gematol Transfuziol; 1989 Sep; 34(9):24-8. PubMed ID: 2583457
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children].
Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1989; (2):30-4. PubMed ID: 2726363
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of standard CD assessment in acute leukemia.
Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
[TBL] [Abstract][Full Text] [Related]
5. [State of nucleolus-forming regions in bone marrow and blood cells in acute leukemia in children].
Ikonnikova OA; Lenskaia RV; Zatsepina OV; Baĭdun LV; Kondratchik KL; Chernov VM
Gematol Transfuziol; 1989 Sep; 34(9):28-33. PubMed ID: 2583458
[TBL] [Abstract][Full Text] [Related]
6. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
[No Abstract] [Full Text] [Related]
7. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
[No Abstract] [Full Text] [Related]
8. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
9. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
10. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
12. Phenotype switch in acute leukemia patients after intensive chemotherapy.
Ihle R; Matthes H; Ihle H
Haematol Blood Transfus; 1989; 32():101-3. PubMed ID: 2625237
[TBL] [Abstract][Full Text] [Related]
13. [Electron microscopy morphometry of cells of patients with different immunologic subvariants of acute lymphoblastic leukemia].
Muskhlishvili LV; Mandzhgaladze MV; Shengelaia AT
Eksp Onkol; 1990; 12(3):31-3. PubMed ID: 2188830
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
15. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia].
Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL
Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919
[No Abstract] [Full Text] [Related]
16. [Monoclonal antibodies ICO-11 in the prognostic evaluation of acute nonlymphoblastic leukemia].
Tupitsyn NN; Volkova MA; Perilov AA; Artem'ev AK
Gematol Transfuziol; 1990 Aug; 35(8):7-9. PubMed ID: 2253864
[TBL] [Abstract][Full Text] [Related]
17. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
18. CD34 antigen expression in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Azuma E; Umemoto M; Kubo M; Ohta Y; Zhang SL; Komada Y; Ito M; Sakurai M
Cancer; 1991 Mar; 67(6):1565-9. PubMed ID: 1705862
[TBL] [Abstract][Full Text] [Related]
19. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
20. Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
Geller RB; Larson RA
Curr Opin Oncol; 1991 Feb; 3(1):30-8. PubMed ID: 2043696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
